Welcome to the Johnson Matthey Hub

Johnson Matthey is a speciality chemicals company using science to make the world cleaner and healthier. More than 90 percent of our sales come from technologies that benefit the environment and health, enhancing people’s lives across the planet. Read more »

Typically recruits

  • Chemical/Process
  • Civil/Building
  • Computing/Technology
  • Electronic & Electrical
  • Materials & Minerals
  • Mechanical/Manufacturing
  • Sciences/Maths
Placements

Opening soon

Undergrad intake: 10+
Graduate intake: 75+
We're a global leader in sustainable technologies.
FTSE 100 company with a 202 year history.
We have operations in over 30 countries and around 14,000 employees.
Our products enhance the quality of life for millions of people every day.
We manufacture catalysts which stop around 20 million tonnes of pollutants in their tracks every year.
We also develop processes to maximise efficient use of natural resources and precious metals.
R&D investment of £193 million.
Over 3,700 students have Followed us on Gradcracker.
A Gradcracker advertiser for at least five years - ideal for your shortlist!

Debra Jones

Chemistry

"In my time at Johnson Matthey I have experienced many areas of the business and learned a wide range of valuable transferable skills . . ."

Read more

Louise Arnold

Technology Director

"Louise's interest in seeing experiments scale up to commercial projects has led to her becoming Technology Director for North America in our largest business"

Read more

Johnson Matthey obtains license for the GEMX advanced battery...

JM has obtained a license under the intellectual property of CAMX relating to the GEMX™ platform of nickel based high energy high power cathode materials for use in lithium-ion batteries especially for electric vehicles (EVs).

Read more

Johnson Matthey partners with Immunomedics to develop life-saving...

Johnson Matthey announced a strategic manufacturing partnership for the large-scale production of the drug-linker used in Immunomedics’ lead antibody-drug conjugate.

Read more